Texas Capital Bancshares Inc/Tx (TCBIO) Enterprise Value (2010 - 2026)

Texas Capital Bancshares (TCBIO) has reported Enterprise Value for 15 consecutive years, with -$4.6 billion the latest figure, recorded in Q2 2026.

• Quarterly Enterprise Value rose 0.96% year-over-year to -$4.6 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$18.6 billion (down 36.39% YoY) and the FY2025 annual result came in at -$4.7 billion, down 7.44% from the prior year.
• Enterprise Value climbed to -$4.6 billion in Q2 2026 per TCBIO's latest filing, from -$4.7 billion in the prior quarter.
• Over the last five years, Enterprise Value for TCBIO reached as high as -$32.7 million in Q1 2023 and fell as low as -$4.7 billion in Q4 2025.
• A 5-year average of -$1.8 billion and a median of -$73.9 million in 2024 frame the typical range for Enterprise Value.
• Annual changes were most pronounced in 2022 — Enterprise Value rose 25.55% — and 2024, when it sank 8382.61%.
• Year by year, Enterprise Value stood at -$34.0 million in 2022, then tumbled by 52.62% to -$51.8 million in 2023, then plunged by 8382.61% to -$4.4 billion in 2024, then fell by 7.44% to -$4.7 billion in 2025, then climbed by 3.36% to -$4.6 billion in 2026.
• According to Business Quant data, Enterprise Value over the past three periods registered -$4.6 billion, -$4.7 billion, and -$4.7 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.